Update date
30 Sep 2023
Shareable Research Card
Orchard Therapeutics plc Amortization of Intangible Assets
This metric view shows Orchard Therapeutics plc amortization of intangible assets history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
- Context
- Latest reported period: Q3 2023
- Latest reported value
- $100,000
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
Why revisit this metric view
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
- Latest source-backed update
- Latest period end 30 Sep 2023
- Why come back
- Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
- Current latest reported period: Q3 2023.
- Latest reported value on this page: $100,000.
- Save this filer if you want to compare the next reported value with this history.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest update for Amortization of Intangible Assets
Latest reported amortization of intangible assets: $100,000. Open the source-backed page to compare this metric with the newest filing-backed context.
Page type
Metric history
Latest period
Q3 2023
SEC-backed company facts were refreshed from filings filed on 13 Nov 2023.
Benchmark Context
How Amortization of Intangible Assets compares with peers
Orchard Therapeutics plc is outside the visible top 120 companies for amortization of intangible assets in the current sample.
Compared with
Compared with 120 companies reporting amortization of intangible assets in USD. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about 0x the current sample midpoint. Amortization of Intangible Assets is roughly flat versus the comparable prior period.
- Visible rows currently span reported period ends from 31 Dec 2013 to 31 Mar 2026.
- Nearby companies in this sample: Warner Bros. Discovery, Inc. and AT&T INC..
- Peer rows use the latest valid value per company for this exact metric and compatible units.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Save this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Financial Metric Page
Orchard Therapeutics plc: Amortization of Intangible Assets
Latest period: Q3 2023. Period end: 30 Sep 2023. Units: USD. Frequency: quarterly and annual.
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Metric Snapshot
- Latest value
- $100,000
- Coverage range
- 31 Dec 2021 - 30 Sep 2023
- Fact rows
- 9
What This Metric Tells You
- Shows the reported level of amortization of intangible assets over 31 Dec 2021 - 30 Sep 2023.
- Includes year-over-year change points to highlight acceleration or slowdown.
- Built from 9 SEC fact rows for this metric and issuer.
How To Read This Chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use quarterly sequence to compare like-for-like periods.
- Use YoY change bars to separate growth from contraction across matching periods.
- Use the TTM line to smooth quarter-to-quarter noise.
Official SEC Source
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare This Metric Across Companies
Compare latest available Amortization of Intangible Assets levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
| Rank | Company | Latest value | Reported period | Next step |
|---|---|---|---|---|
| 1 | Warner Bros. Discovery, Inc. (wbd) | $4,605,000,000 | Year - 31 Dec 2025 | Open Warner Bros. Discovery, Inc. Amortization of Intangible Assets |
| 2 | AT&T INC. (t) | $4,288,000,000 | Year - 31 Dec 2021 | Open AT&T INC. Amortization of Intangible Assets |
| 3 | Merck & Co., Inc. (mrk) | $2,800,000,000 | Year - 31 Dec 2025 | Open Merck & Co., Inc. Amortization of Intangible Assets |
| 4 | GILEAD SCIENCES, INC. (gild) | $2,400,000,000 | Year - 31 Dec 2025 | Open GILEAD SCIENCES, INC. Amortization of Intangible Assets |
| 5 | Broadcom Inc. (avgo) | $1,969,000,000 | Quarter - 01 Feb 2026 | Open Broadcom Inc. Amortization of Intangible Assets |
| 6 | Alibaba Group Holding Ltd (baba) | $1,819,000,000 | Year - 31 Mar 2025 | Open Alibaba Group Holding Ltd Amortization of Intangible Assets |
Metric Details
- Metric
- Amortization of Intangible Assets (AmortizationOfIntangibleAssets)
- Taxonomy
- us-gaap
- Units tracked
- USD
- Frequency coverage
- quarterly and annual
- History range
- 31 Dec 2021 - 30 Sep 2023
- Facts on this page
- 9
- Description
- The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
- Metric-level SEC endpoint
- Open SEC company concept
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Change (%)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Change (%)
Orchard Therapeutics plc Quarterly Amortization of Intangible Assets (USD)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q3 2023 | $300,000 | $100,000 | $0 | 0% | 01 Jul 2023 | 30 Sep 2023 | 10-Q | 13 Nov 2023 | 2023 | Q3 |
| Q2 2023 | $300,000 | $100,000 | $0 | 0% | 01 Apr 2023 | 30 Jun 2023 | 10-Q | 10 Aug 2023 | 2023 | Q2 |
| Q1 2023 | $300,000 | $100,000 | $0 | 0% | 01 Jan 2023 | 31 Mar 2023 | 10-Q | 15 May 2023 | 2023 | Q1 |
| Q4 2022 | $300,000 | $0 | 01 Oct 2022 | 31 Dec 2022 | 10-K | 14 Mar 2023 | 2022 | FY | ||
| Q3 2022 | $100,000 | 01 Jul 2022 | 30 Sep 2022 | 10-Q | 13 Nov 2023 | 2023 | Q3 | |||
| Q2 2022 | $100,000 | 01 Apr 2022 | 30 Jun 2022 | 10-Q | 10 Aug 2023 | 2023 | Q2 | |||
| Q1 2022 | $100,000 | 01 Jan 2022 | 31 Mar 2022 | 10-Q | 15 May 2023 | 2023 | Q1 |
Orchard Therapeutics plc Annual Amortization of Intangible Assets (USD)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2022 | $300,000 | +$100,000 | +50% | 01 Jan 2022 | 31 Dec 2022 | 10-K | 14 Mar 2023 | 2022 | FY |
| 2021 | $200,000 | 01 Jan 2021 | 31 Dec 2021 | 10-K | 14 Mar 2023 | 2022 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.